期刊
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
卷 64, 期 6, 页码 734-746出版社
AMER THORACIC SOC
DOI: 10.1165/rcmb.2020-0303OC
关键词
AXL; pulmonary fibrosis; R428; tobacco smoking; fibroblasts
资金
- California University of California Office of The President Tobacco-Related Disease Research Program [27KT-0004, 28IR-0061, T31DT1849]
- U.S. National Institutes of Health grant National Heart, Lung, and Blood Institute [R01HL146802]
Tobacco smoking can induce highly proliferative and invasive activities in lung fibroblasts, leading to fibrotic lung lesions in mice. Genetic suppression of AXL in smoke-exposed fibroblasts inhibits AXL downstream pathways and aggressive phenotypes. Pharmacological inhibition of AXL may be a potential therapeutic strategy in treating tobacco smoking-related pulmonary fibrosis.
Tobacco smoking is a well-known risk factor for both fibrogenesis and fibrotic progression; however, the mechanisms behind these processes remain enigmatic. RTKs (receptor tyrosine kinases) have recently been reported to drive profibrotic phenotypes in fibroblasts during pulmonary fibrosis (PF). Using a phospho-RTK array screen, we identified the RTK AXL as a top upregulated RTK in response to smoke. Both expression and signaling activity of AXL were indeed elevated in lung fibroblasts exposed to tobacco smoke, whereas no significant change to the levels of a canonicalAXLligand, Gas6 (growth arrest-specific 6), was seen upon smoke treatment. Notably, we found that smoke-exposed human lung fibroblasts exhibited highly proliferative and invasive activities and were capable of inducing fibrotic lung lesions in mice. Conversely, genetic suppression ofAXL in smoke-exposed fibroblasts cells led to suppression ofAXL downstream pathways and aggressive phenotypes. We further demonstrated that AXL interacted with MARCKS (myristoylated alanine-rich C kinase substrate) and cooperated with MARCKS in regulating downstream signaling activity and fibroblast invasiveness. Pharmacological inhibition ofAXL with AXL-specific inhibitor R428 showed selectivity for smoke-exposed fibroblasts. In all, our data suggest that AXL is a potential marker for smoke-associated PF and that targeting of the AXL pathway is a potential therapeutic strategy in treating tobacco smoking-related PF.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据